If CHIP alone confers an increased risk of accelerated progression of atherosclerosis and heart failure, other cardiac disorders, and related arterial thrombosis, then surely the clinically diagnosed MPNs should be associated with at least the same risk. This evidence concerns the gene STUB1 and heart failure.